Sepsis target validation for repurposing and combining complement and immune checkpoint inhibition therapeutics.

Expert Opinion on Drug Discovery
Patrícia R S RodriguesPeter Ghazal

Abstract

Introduction: Sepsis is a disease that occurs due to an adverse immune response to infection by bacteria, viruses and fungi and is the leading pathway to death by infection. The hallmarks for maladapted immune reactions in severe sepsis, which contribute to multiple organ failure and death, are bookended by the exacerbated activation of the complement system to protracted T-cell dysfunction states orchestrated by immune checkpoint control. Despite major advances in our understanding of the condition, there remains to be either a definitive test or an effective therapeutic intervention.Areas covered: The authors consider a combinational drug therapy approach using new biologics, and mathematical modeling for predicting patient responses, in targeting innate and adaptive immune mediators underlying sepsis. Special consideration is given for emerging complement and immune checkpoint inhibitors that may be repurposed for sepsis treatment.Expert opinion: In order to overcome the challenges inherent to finding new therapies for the complex dysregulated host response to infection that drives sepsis, it is necessary to move away from monotherapy and promote precision for personalized combinatory therapies. Notably, combinatory therapy ...Continue Reading

References

Mar 1, 1989·The Journal of Surgical Research·D H HangenT A Raffin
Nov 1, 1986·The American Review of Respiratory Disease·D C BrockmannT A Raffin
Jul 1, 1985·British Medical Bulletin·A R McPhaden, K Whaley
Jan 27, 1994·Nature·J EmsleyS P Wood
Feb 2, 1996·The Journal of Biological Chemistry·M MatsushitaT Mizuochi
May 6, 1998·European Journal of Clinical Investigation·M MohrH Burchardi
Jul 17, 1998·QJM : Monthly Journal of the Association of Physicians·K D Horn
Jul 8, 1999·Nature Medicine·B J CzermakP A Ward
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MatsushitaT Fujita
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M MatsushitaT Fujita
May 30, 2002·Nature Reviews. Immunology·Teizo Fujita
Jan 14, 2003·Annual Review of Immunology·Uffe HolmskovJens C Jensenius
Jan 28, 2003·The American Journal of Pathology·Gregory L StahlHui Zhao
Mar 21, 2003·European Journal of Immunology·Alma J NautaAnja Roos
Jul 11, 2003·Clinical and Diagnostic Laboratory Immunology·Sacha ZeerlederWalter A Wuillemin
Mar 26, 2004·Nature Reviews. Immunology·Peter A Ward
May 4, 2004·Nature Reviews. Immunology·Lieping Chen
Sep 11, 2004·Immunity·Tsvetelina Pentcheva-HoangJames P Allison
Oct 13, 2004·Circulation·Roberto LatiniUNKNOWN Lipid Assessment Trial Italian Network (LATIN) Investigators
Mar 18, 2005·Annual Review of Immunology·Ren-Feng Guo, Peter A Ward
Oct 6, 2006·Journal of Leukocyte Biology·Daniel RittirschPeter A Ward
Nov 30, 2006·Intensive Care Medicine·Stefanos Geroulanos, Evangelia T Douka
Jul 21, 2007·The American Journal of Pathology·Maciej M Markiewski, John D Lambris
Oct 20, 2007·European Journal of Immunology·Sandrijn M van Schaik, Abul K Abbas
Jan 4, 2008·Journal of Leukocyte Biology·John C Marshall
Jan 31, 2008·Journal of Neuroinflammation·Piali MukherjeeGiulio Maria Pasinetti
May 6, 2008·Nature Medicine·Daniel RittirschPeter A Ward
Sep 19, 2008·Journal of Cellular and Molecular Medicine·Maciej M MarkiewskiJohn D Lambris
Sep 20, 2008·Nature Reviews. Immunology·Daniel RittirschPeter A Ward
Jan 30, 2009·Journal of Clinical Biochemistry and Nutrition·Shoichi EzakiMasanori Tamura
Apr 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xin HuangAlfred Ayala
May 15, 2009·Critical Care : the Official Journal of the Critical Care Forum·Djillali Annane
Jul 28, 2009·The Journal of Biological Chemistry·Ying Jie MaPeter Garred
Sep 4, 2009·Journal of Cellular and Molecular Medicine·Peter A Ward, Hongwei Gao
Sep 5, 2009·Nature Reviews. Immunology·Peter F Zipfel, Christine Skerka
Dec 9, 2009·Annual Review of Immunology·Barbara BottazziAlberto Mantovani
May 21, 2010·Journal of Leukocyte Biology·Pavan BrahmamdamRichard S Hotchkiss
Jul 1, 2010·Journal of Innate Immunity·Peter A Ward
Aug 10, 2010·Critical Care Medicine·Mirrin J DorresteijnPeter Pickkers
Aug 20, 2010·Nature Immunology·Daniel RicklinJohn D Lambris
Oct 28, 2010·JAMA : the Journal of the American Medical Association·Theodore J IwashynaKenneth M Langa
Dec 2, 2010·Critical Care : the Official Journal of the Critical Care Forum·Yan ZhangZailong Cai
Feb 26, 2011·Critical Care : the Official Journal of the Critical Care Forum·Yan ZhangXiaoming Deng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved